{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T10:27:09Z","timestamp":1781778429093,"version":"3.54.5"},"reference-count":102,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cell Biology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.tcb.2020.11.003","type":"journal-article","created":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:20:19Z","timestamp":1606782019000},"page":"197-210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Fukutin-Related Protein: From Pathology to Treatments"],"prefix":"10.1016","volume":"31","author":[{"given":"Carolina","family":"Ortiz-Cordero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Azzag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9412-1118","authenticated-orcid":false,"given":"Rita C.R.","family":"Perlingeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcb.2020.11.003_bb0005","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.spen.2005.10.003","article-title":"The dystroglycanopathies: the new disorders of O-linked glycosylation","volume":"12","author":"Martin","year":"2005","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.tcb.2020.11.003_bb0010","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1083\/jcb.122.4.809","article-title":"A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin","volume":"122","author":"Ervasti","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.tcb.2020.11.003_bb0015","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/355696a0","article-title":"Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix","volume":"355","author":"Ibraghimov-Beskrovnaya","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.tcb.2020.11.003_bb0020","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/glycob\/cwx062","article-title":"Recent advancements in understanding mammalian O-mannosylation","volume":"27","author":"Sheikh","year":"2017","journal-title":"Glycobiology"},{"key":"10.1016\/j.tcb.2020.11.003_bb0025","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1086\/324412","article-title":"Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin \u237a2 deficiency and abnormal glycosylation of \u03b1-dystroglycan","volume":"69","author":"Brockington","year":"2001","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.tcb.2020.11.003_bb0030","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1093\/hmg\/10.25.2851","article-title":"Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C","volume":"10","author":"Brockington","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tcb.2020.11.003_bb0035","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1136\/jmg.2003.013870","article-title":"Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker\u2013Warburg syndrome","volume":"41","author":"Beltran-Valero de Bernabe","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.tcb.2020.11.003_bb0040","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/acn3.649","article-title":"Genetic landscape and novel disease mechanisms from a large LGMD cohort of 4656 patients","volume":"5","author":"Nallamilli","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.tcb.2020.11.003_bb0045","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000408","article-title":"Molecular diagnosis of muscular diseases in outpatient clinics: a Canadian perspective","volume":"6","author":"Thuriot","year":"2020","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.tcb.2020.11.003_bb0050","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.14473","article-title":"The functional O-mannose glycan on \u03b1-dystroglycan contains a phospho-ribitol primed for matriglycan addition","volume":"5","author":"Praissman","year":"2016","journal-title":"Elife"},{"key":"10.1016\/j.tcb.2020.11.003_bb0055","doi-asserted-by":"crossref","first-page":"11534","DOI":"10.1038\/ncomms11534","article-title":"ISPD produces CDP-ribitol used by FKTN and FKRP to transfer ribitol phosphate onto \u03b1-dystroglycan","volume":"7","author":"Gerin","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2020.11.003_bb0060","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.celrep.2016.02.017","article-title":"Identification of a post-translational modification with ribitol-phosphate and its defect in muscular dystrophy","volume":"14","author":"Kanagawa","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.tcb.2020.11.003_bb0065","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1242\/jcs.02814","article-title":"Dystroglycan: from biosynthesis to pathogenesis of human disease","volume":"119","author":"Barresi","year":"2006","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.tcb.2020.11.003_bb0070","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/nn.2160","article-title":"Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation","volume":"11","author":"Sato","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.tcb.2020.11.003_bb0075","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.neuron.2012.10.009","article-title":"Dystroglycan organizes axon guidance cue localization and axonal pathfinding","volume":"76","author":"Wright","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.tcb.2020.11.003_bb0080","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/jb\/mvy020","article-title":"Ribitol-phosphate \u2013 a newly identified posttranslational glycosylation unit in mammals: structure, modification enzymes and relationship to human diseases","volume":"163","author":"Kanagawa","year":"2018","journal-title":"J. Biochem."},{"key":"10.1016\/j.tcb.2020.11.003_bb0085","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.035931","article-title":"The roles of dystroglycan in the nervous system: insights from animal models of muscular dystrophy","volume":"11","author":"Nickolls","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.tcb.2020.11.003_bb0090","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1093\/hmg\/11.26.3319","article-title":"Functional requirements for fukutin-related protein in the Golgi apparatus","volume":"11","author":"Esapa","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tcb.2020.11.003_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022968","article-title":"Fukutin-related protein resides in the Golgi cisternae of skeletal muscle fibres and forms disulfide-linked homodimers via an N-terminal interaction","volume":"6","author":"Alhamidi","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.tcb.2020.11.003_bb0100","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41467-019-14220-z","article-title":"Crystal structures of fukutin-related protein (FKRP), a ribitol-phosphate transferase related to muscular dystrophy","volume":"11","author":"Kuwabara","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2020.11.003_bb0105","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/ana.10559","article-title":"Phenotypic spectrum associated with mutations in the fukutin-related protein dene","volume":"53","author":"Mercuri","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.tcb.2020.11.003_bb0110","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.nmd.2016.08.012","article-title":"216th ENMC international workshop: clinical readiness in FKRP related myopathies January 15\u201317, 2016 Naarden, The Netherlands","volume":"26","author":"Richard","year":"2016","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.tcb.2020.11.003_bb0115","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/mus.21432","article-title":"Cardiac pathology exceeds skeletal muscle pathology in two cases of limb-girdle muscular dystrophy type 2I","volume":"40","author":"Margeta","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.tcb.2020.11.003_bb0120","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/acn3.51042","article-title":"Global FKRP Registry: observations in more than 300 patients with Limb Girdle Muscular Dystrophy R9","volume":"7","author":"Murphy","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.tcb.2020.11.003_bb0125","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0002-9440(10)63160-4","article-title":"Abnormalities in \u03b1-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies","volume":"164","author":"Brown","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tcb.2020.11.003_bb0130","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.braindev.2006.09.006","article-title":"A novel FKRP gene mutation in a Taiwanese patient with limb-girdle muscular dystrophy 2I","volume":"29","author":"Lin","year":"2007","journal-title":"Brain Dev."},{"key":"10.1016\/j.tcb.2020.11.003_bb0135","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0092-8674(91)90035-W","article-title":"Membrane organization of the dystrophin-glucoprotein complex","volume":"66","author":"Ervasti","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.tcb.2020.11.003_bb0140","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1369\/jhc.2008.951772","article-title":"Muscle protein alterations in LGMD2I patients with different mutations in the fukutin-related protein gene","volume":"56","author":"Yamamoto","year":"2008","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.tcb.2020.11.003_bb0145","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1750-3639.2008.00198.x","article-title":"A comparative study of \u03b1-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of \u03b1-dystroglycan does not consistently correlate with clinical severity","volume":"19","author":"Jimenez-Mallebrera","year":"2009","journal-title":"Brain Pathol."},{"key":"10.1016\/j.tcb.2020.11.003_bb0150","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.nmd.2017.02.015","article-title":"Limb girdle muscular dystrophy type 2I: no correlation between clinical severity, histopathology and glycosylated \u03b1-dystroglycan levels in patients homozygous for common FKRP mutation","volume":"27","author":"Alhamidi","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.tcb.2020.11.003_bb0155","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1172\/JCI60434","article-title":"Hooked! Modeling human disease in zebrafish","volume":"122","author":"Santoriello","year":"2012","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.tcb.2020.11.003_bb0160","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3233\/JND-190389","article-title":"Discovery of novel therapeutics for muscular dystrophies using zebrafish phenotypic screens","volume":"6","author":"Widrick","year":"2019","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.tcb.2020.11.003_bb0165","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/brain\/awn078","article-title":"Developmental defects in a zebrafish model for muscular dystrophies associated with the loss of fukutin-related protein (FKRP)","volume":"131","author":"Thornhill","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.tcb.2020.11.003_bb0170","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/hmg\/ddr059","article-title":"Zebrafish fukutin family proteins link the unfolded protein response with dystroglycanopathies","volume":"20","author":"Lin","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tcb.2020.11.003_bb0175","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/hmg\/ddp528","article-title":"Zebrafish models for human FKRP muscular dystrophies","volume":"19","author":"Kawahara","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tcb.2020.11.003_bb0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13395-019-0206-1","article-title":"NAD+ improves neuromuscular development in a zebrafish model of FKRP-associated dystroglycanopathy","volume":"9","author":"Bailey","year":"2019","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.tcb.2020.11.003_bb0185","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1093\/hmg\/ddr426","article-title":"Abnormal vascular development in zebrafish models for fukutin and FKRP deficiency","volume":"20","author":"Wood","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tcb.2020.11.003_bb0195","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.120493","article-title":"A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathies","volume":"3","author":"Serafini","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.tcb.2020.11.003_bb0200","doi-asserted-by":"crossref","first-page":"12927","DOI":"10.1523\/JNEUROSCI.2301-11.2011","article-title":"Fukutin-related protein alters the deposition of laminin in the eye and brain","volume":"31","author":"Ackroyd","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.tcb.2020.11.003_bb0205","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1093\/hmg\/ddt577","article-title":"The transgenic expression of LARGE exacerbates the muscle phenotype of dystroglycanopathy mice","volume":"23","author":"Whitmore","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tcb.2020.11.003_bb0210","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1093\/hmg\/ddq314","article-title":"Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies","volume":"19","author":"Chan","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tcb.2020.11.003_bb0215","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1007\/s00439-013-1302-7","article-title":"Mouse models of fukutin-related protein mutations show a wide range of disease phenotypes","volume":"132","author":"Blaeser","year":"2013","journal-title":"Hum. Genet."},{"key":"10.1016\/j.tcb.2020.11.003_bb0220","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ajpath.2010.11.020","article-title":"Post-natal knockdown of fukutin-related protein expression in muscle by long-termRNA interference induces dystrophic pathology [corrected]","volume":"178","author":"Wang","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tcb.2020.11.003_bb0225","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1038\/mt.2014.141","article-title":"Muscle and heart function restoration in a limb girdle muscular dystrophy 2I (LGMD2I) mouse model by systemic FKRP gene delivery","volume":"22","author":"Qiao","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tcb.2020.11.003_bb0230","first-page":"1137","article-title":"A new mouse model of limb-girdle muscular dystrophy type 2I homozygous for the common L276I mutation mimicking the mild phenotype in humans","volume":"74","author":"Krag","year":"2015","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.tcb.2020.11.003_bb0235","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1093\/hmg\/ddx066","article-title":"AAV-mediated transfer of FKRP shows therapeutic efficacy in a murine model but requires control of gene expression","volume":"26","author":"Gicquel","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tcb.2020.11.003_bb0240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183837","article-title":"Mouse models of human ocular disease for translational research","volume":"12","author":"Krebs","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.tcb.2020.11.003_bb0245","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13395-020-00228-3","article-title":"Efficient engraftment of pluripotent stem cell-derived myogenic progenitors in a novel immunodeficient mouse model of limb girdle muscular dystrophy 2I","volume":"10","author":"Azzag","year":"2020","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.tcb.2020.11.003_bb0250","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","article-title":"Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R\u03b3null mice engrafted with mobilized human hemopoietic stem cells","volume":"174","author":"Shultz","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.tcb.2020.11.003_bb0255","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1001\/archneur.62.12.1894","article-title":"Clinical and molecular characterization of patients with limb-girdle muscular dystrophy type 2I","volume":"62","author":"Boito","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.tcb.2020.11.003_bb0260","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.nmd.2005.09.004","article-title":"Sub-cellular localisation of fukutin related protein in different cell lines and in the muscle of patients with MDC1C and LGMD2I","volume":"15","author":"Torelli","year":"2005","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.tcb.2020.11.003_bb0265","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/ng.2252","article-title":"ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome","volume":"44","author":"Willer","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.tcb.2020.11.003_bb0270","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0068958","article-title":"Flow cytometry for the analysis of \u03b1-dystroglycan glycosylation in fibroblasts from patients with dystroglycanopathies","volume":"8","author":"Stevens","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.tcb.2020.11.003_bb0275","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/humu.23827","article-title":"Functional and cellular localization diversity associated with fukutin-related protein patient genetic variants","volume":"40","author":"Henriques","year":"2019","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.tcb.2020.11.003_bb0280","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.tcb.2020.11.003_bb0285","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s40778-018-0145-5","article-title":"Human iPSC models to study orphan diseases: muscular dystrophies","volume":"4","author":"Xia","year":"2018","journal-title":"Curr. Stem Cell Rep."},{"key":"10.1016\/j.tcb.2020.11.003_bb0290","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.117.001893","article-title":"Ion channel dysfunctions in dilated cardiomyopathy in limb-girdle muscular dystrophy","volume":"11","author":"El-Battrawy","year":"2018","journal-title":"Circ. Genom. Precis. Med."},{"key":"10.1016\/j.tcb.2020.11.003_bb0295","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201947967","article-title":"A new patient-derived iPSC model for dystroglycanopathies validates a compound that increases glycosylation of \u03b1-dystroglycan","volume":"20","author":"Kim","year":"2019","journal-title":"EMBO Rep."},{"key":"10.1016\/j.tcb.2020.11.003_bb0300","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.042986","article-title":"Human embryoid bodies as a 3D tissue model of the extracellular matrix and \u237a-dystroglycanopathies","volume":"13","author":"Nickolls","year":"2020","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.tcb.2020.11.003_bb0305","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.ajpath.2016.02.015","article-title":"Glucocorticoid steroid and alendronate treatment alleviates dystrophic phenotype with enhanced functional glycosylation of \u03b1-dystroglycan in mouse model of limb girdle muscular dystrophy with FKRPP448L mutation","volume":"186","author":"Wu","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tcb.2020.11.003_bb0310","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ajpath.2017.12.011","article-title":"Long-term treatment of tamoxifen and raloxifene alleviates dystrophic phenotype and enhances muscle functions of FKRP dystroglycanopathy","volume":"188","author":"Wu","year":"2018","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tcb.2020.11.003_bb0315","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/WCO.0000000000000739","article-title":"Update in Duchenne and Becker muscular dystrophy","volume":"32","author":"Waldrop","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.tcb.2020.11.003_bb0320","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/WCO.0000000000000603","article-title":"Bones and muscular dystrophies: what do we know?","volume":"31","author":"Wood","year":"2018","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.tcb.2020.11.003_bb0325","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ajpath.2012.10.018","article-title":"The anticancer drug tamoxifen counteracts the pathology in a mouse model of Duchenne muscular dystrophy","volume":"182","author":"Dorchies","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tcb.2020.11.003_bb0330","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1038\/s41467-018-05990-z","article-title":"Ribitol restores functionally glycosylated \u03b1-dystroglycan and improves muscle function in dystrophic FKRP-mutant mice","volume":"9","author":"Cataldi","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2020.11.003_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001409","article-title":"NAD+ biosynthesis ameliorates a zebrafish model of muscular dystrophy","volume":"10","author":"Goody","year":"2012","journal-title":"PLoS Biol."},{"key":"10.1016\/j.tcb.2020.11.003_bb0340","doi-asserted-by":"crossref","first-page":"R102","DOI":"10.1093\/hmg\/ddz128","article-title":"AAV-based gene therapies for the muscular dystrophies","volume":"28","author":"Crudele","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tcb.2020.11.003_bb0345","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1038\/mt.2013.156","article-title":"Adeno-associated virus 9 mediated FKRP gene therapy restores functional glycosylation of \u03b1-dystroglycan and improves muscle functions","volume":"21","author":"Xu","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tcb.2020.11.003_bb0350","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/hgtb.2013.151","article-title":"Adeno-associated virus-mediated overexpression of LARGE rescues \u03b1-dystroglycan function in dystrophic mice with mutations in the fukutin-related protein","volume":"25","author":"Vannoy","year":"2014","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.tcb.2020.11.003_bb0355","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1016\/j.ajpath.2016.05.021","article-title":"B4GALNT2 (GALGT2) gene therapy reduces skeletal muscle pathology in the FKRP P448L mouse model of limb girdle muscular dystrophy 2I","volume":"186","author":"Thomas","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tcb.2020.11.003_bb0360","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.omtm.2018.10.004","article-title":"Dose-dependent effects of FKRP gene-replacement therapy on functional rescue and longevity in dystrophic mice","volume":"11","author":"Vannoy","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.tcb.2020.11.003_bb0365","doi-asserted-by":"crossref","first-page":"10070","DOI":"10.1038\/s41598-019-46431-1","article-title":"Metabolomics analysis of skeletal muscles from FKRP-deficient mice indicates improvement after gene replacement therapy","volume":"9","author":"Vannoy","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tcb.2020.11.003_bb0370","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/nm1059","article-title":"LARGE can functionally bypass \u03b1-dystroglycan glycosylation defects in distinct congenital muscular dystrophies","volume":"10","author":"Barresi","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.tcb.2020.11.003_bb0375","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/hum.2012.084","article-title":"Adeno-associated viral-mediated LARGE gene therapy rescues the muscular dystrophic phenotype in mouse models of dystroglycanopathy","volume":"24","author":"Yu","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.tcb.2020.11.003_bb0380","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1006\/dbio.2001.0530","article-title":"Overexpression of the CT GalNAc transferase in skeletal muscle alters myofiber growth, neuromuscular structure, and laminin expression","volume":"242","author":"Xia","year":"2002","journal-title":"Dev. Biol."},{"key":"10.1016\/j.tcb.2020.11.003_bb0385","doi-asserted-by":"crossref","first-page":"5616","DOI":"10.1073\/pnas.082613599","article-title":"Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice","volume":"99","author":"Nguyen","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tcb.2020.11.003_bb0390","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2353\/ajpath.2007.060927","article-title":"Overexpression of the cytotoxic T cell (CT) carbohydrate inhibits muscular dystrophy in the dyW mouse model of congenital muscular dystrophy 1A","volume":"171","author":"Xu","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tcb.2020.11.003_bb0395","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2353\/ajpath.2009.080967","article-title":"Overexpression of Galgt2 reduces dystrophic pathology in the skeletal muscles of alpha sarcoglycan-deficient mice","volume":"175","author":"Xu","year":"2009","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tcb.2020.11.003_bb0400","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.omtm.2019.12.005","article-title":"ISPD overexpression enhances ribitol-induced glycosylation of \u03b1-dystroglycan in dystrophic FKRP mutant mice","volume":"17","author":"Cataldi","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.tcb.2020.11.003_bb0405","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1093\/hmg\/ddx252","article-title":"Autologous intramuscular transplantation of engineered satellite cells induces exosome-mediated systemic expression of fukutin-related protein and rescues disease phenotype in a murine model of limb-girdle muscular dystrophy type 2I","volume":"26","author":"Frattini","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.tcb.2020.11.003_bb0410","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/nm1705","article-title":"Functional skeletal muscle regeneration from differentiating embryonic stem cells","volume":"14","author":"Darabi","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.tcb.2020.11.003_bb0415","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.stem.2012.02.015","article-title":"Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice","volume":"10","author":"Darabi","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tcb.2020.11.003_bb0420","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/ncomms2550","article-title":"An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells","volume":"4","author":"Filareto","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tcb.2020.11.003_bb0425","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.ymthe.2019.08.011","article-title":"Gene correction of LGMD2A patient-specific iPSCs for the development of targeted autologous cell therapy","volume":"27","author":"Selvaraj","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tcb.2020.11.003_bb0430","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.molmed.2019.07.004","article-title":"Pluripotent stem cell-based therapeutics for muscular dystrophies","volume":"25","author":"Selvaraj","year":"2019","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.tcb.2020.11.003_bb0435","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00428-007-0515-3","article-title":"Biochemical and ultrastructural evidence of endoplasmic reticulum stress in LGMD2I","volume":"451","author":"Boito","year":"2007","journal-title":"Virchows Arch."},{"key":"10.1016\/j.tcb.2020.11.003_bb0440","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/jb\/mvh086","article-title":"Subcellular localization of fukutin and fukutin-related protein in muscle cells","volume":"135","author":"Matsumoto","year":"2004","journal-title":"J. Biochem."},{"key":"10.1016\/j.tcb.2020.11.003_bb0445","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/mus.20833","article-title":"Fukutin-related protein localizes to the Golgi apparatus and mutations lead to mislocalization in muscle in vivo","volume":"36","author":"Keramaris-Vrantsis","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.tcb.2020.11.003_bb0450","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","article-title":"Immune responses to viral gene therapy vectors","volume":"28","author":"Shirley","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tcb.2020.11.003_bb0455","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/mt.2016.20","article-title":"Timing of gene therapy interventions: the earlier, the better","volume":"24","author":"Gray","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.tcb.2020.11.003_bb0460","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.omtm.2017.02.002","article-title":"Efficacy of gene therapy is dependent on disease progression in dystrophic mice with mutations in the FKRP gene","volume":"5","author":"Vannoy","year":"2017","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.tcb.2020.11.003_bb0465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12015-014-9574-4","article-title":"Banking on iPSC--is it doable and is it worthwhile","volume":"11","author":"Solomon","year":"2015","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.tcb.2020.11.003_bb0470","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.stem.2013.08.003","article-title":"Toward the development of a global induced pluripotent stem cell library","volume":"13","author":"Turner","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tcb.2020.11.003_bb0475","doi-asserted-by":"crossref","first-page":"518135","DOI":"10.1155\/2014\/518135","article-title":"Potential and limitation of HLA-based banking of human pluripotent stem cells for cell therapy","volume":"2014","author":"de Rham","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/j.tcb.2020.11.003_bb0480","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.stem.2012.07.014","article-title":"Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types","volume":"11","author":"Taylor","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.tcb.2020.11.003_bb0485","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0014-5793(00)01195-9","article-title":"Biosynthesis of dystroglycan: processing of a precursor propeptide","volume":"468","author":"Holt","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tcb.2020.11.003_bb0490","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1073\/pnas.0307228101","article-title":"Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity","volume":"101","author":"Manya","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.tcb.2020.11.003_bb0495","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1126\/science.1239951","article-title":"SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function","volume":"341","author":"Yoshida-Moriguchi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.tcb.2020.11.003_bb0500","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1126\/science.1214115","article-title":"Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE","volume":"335","author":"Inamori","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.tcb.2020.11.003_bb0505","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03941","article-title":"The glucuronyltransferase B4GAT1 is required for initiation of LARGE-mediated \u03b1-dystroglycan functional glycosylation","volume":"3","author":"Willer","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.tcb.2020.11.003_bb0510","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.03943","article-title":"B4GAT1 is the priming enzyme for the LARGE-dependent functional glycosylation of \u03b1-dystroglycan","volume":"3","author":"Praissman","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.tcb.2020.11.003_bb0515","doi-asserted-by":"crossref","first-page":"24618","DOI":"10.1074\/jbc.M116.751917","article-title":"The muscular dystrophy gene TMEM5 encodes a ribitol \u03b21,4-xylosyltransferase required for the functional glycosylation of dystroglycan","volume":"291","author":"Manya","year":"2016","journal-title":"J. Biol. Chem."}],"container-title":["Trends in Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0962892420302282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0962892420302282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T12:55:05Z","timestamp":1760792105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0962892420302282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":102,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0962892420302282"],"URL":"https:\/\/doi.org\/10.1016\/j.tcb.2020.11.003","relation":{},"ISSN":["0962-8924"],"issn-type":[{"value":"0962-8924","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fukutin-Related Protein: From Pathology to Treatments","name":"articletitle","label":"Article Title"},{"value":"Trends in Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcb.2020.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}